2. Disease Areas
  3. Urogenital Disease
  4. Male Reproductive System Disease
  5. Prostatic Hyperplasia

Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH) is a noncancerous enlargement of the prostate gland commonly affecting men over 40, leading to urinary symptoms such as weak urine flow, frequent urination, urgency, and potential complications like urinary retention, urinary tract infections, bladder stones, and renal impairment.

Prostatic Hyperplasia (1):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-W724254
    SNAP-6201 252201-38-0
    SNAP-6201 is a selective α1a adrenoceptor antagonist with a Ki of 0.2 nM. SNAP-6201 exhibits >1400-fold selectivity over α1b and α1d adrenoceptors. SNAP-6201 exhibits excellent selectively to inhibit intraurethral pressure (IUP) in the anesthetized dog model. SNAP-6201 can be used for benign prostatic hyperplasia (BPH) research.
    SNAP-6201